Lv1
30 积分 2026-07-05 加入
JMB2403, a potential best-in-class PD-1-dependent IL2Rβγ-activating tri-specific antibody for safe and potent immunotherapy
16天前
已完结
Therapeutic efficacy and antigenicity of a novel PEGylated IgA protease in preclinical models of IgA nephropathy
24天前
已完结
Transforming mRNA drug design with AI: From UTRand codon optimization to coordinated design;
1个月前
已完结
皖公网安备34019202002308
